Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NRT and lung cancer?

This article was originally published in The Tan Sheet

Executive Summary

It is "a possibility that exposure to nicotine, by smoking or through nicotine supplements, might negatively impact the response to chemotherapeutic agents," Piyali Dasgupta, H. Lee Moffitt Cancer Research Center, Tampa, FL, et al., report at the American Association for Cancer Research annual meeting in Washington, D.C. April 2. Although nicotine is not a carcinogen, "it can induce cell proliferation" and suppress the killing of cancer cells induced by certain agents, the authors note. Their study finds that administering nicotine (1 µm) inhibited treatments for non-small cell lung cancer, such as gemcitabine, cisplatin and taxol...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS099266

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel